MDLN
Medline Inc.
42.16
+1.58 (+3.89%)
52w low 31.37
50.88 high
55.3% of range
Financial Analysis
| Ratio | Mar 25 | Jun 25 | Sep 25 | Dec 25 | Mar 26 | Jun 26 | Sep 26 | Trend |
|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||
| Gross Margin | 27.5% | -- | -- | 24.6% | 25.0% | 28.8% | 24.5% | |
| Operating Margin | 8.6% | -- | -- | 5.5% | 5.7% | 5.1% | 6.4% | |
| EBITDA Margin | -- | -- | -- | 8.1% | 9.7% | 8.6% | 10.3% | |
| Net Margin | 4.8% | -- | -- | 2.3% | 1.8% | 0.8% | 2.5% | |
| FCF Margin | -- | -- | -- | 1.2% | 4.3% | 7.9% | 11.3% | |
| Returns | ||||||||
| Return on Equity | -- | -- | -- | 1.7% | 1.1% | 0.5% | 1.7% | |
| Return on Assets | -- | -- | -- | 0.5% | 0.3% | 0.2% | 0.5% | |
| Return on Inv Capital | -- | -- | 2.8% | 1.4% | 1.6% | 1.0% | 1.9% | |
| Liquidity | ||||||||
| Current Ratio | -- | -- | -- | 4.29x | 4.41x | 4.33x | 4.04x | |
| Quick Ratio | -- | -- | -- | 2.37x | 2.51x | 2.61x | 2.51x | |
| Cash Ratio | -- | -- | -- | 0.78x | 0.88x | 0.86x | 0.74x | |
| Leverage | ||||||||
| Debt / Equity | -- | -- | -- | 1.18x | 1.12x | 1.09x | 1.07x | |
| Net Debt / EBITDA | -- | -- | -- | 16.78x | 14.56x | 15.55x | 12.67x | |
| Interest Coverage | -- | -- | 2.39x | 2.24x | 2.76x | 2.40x | 3.34x | |
| Equity Multiplier | -- | -- | -- | 3.58x | 3.46x | 3.40x | 3.40x | |
| Efficiency | ||||||||
| Asset Turnover | -- | -- | -- | 0.20x | 0.19x | 0.20x | 0.20x | |
| Inventory Turnover | -- | -- | -- | 1.23x | 1.15x | 1.17x | 1.23x | |
| Effective Tax Rate | 4.7% | -- | -- | 12.6% | 17.9% | 40.9% | 17.6% | |
| Op CF / Net Income | -- | -- | -- | 1.26x | 3.19x | 11.92x | 5.26x | |
| Investment | ||||||||
| Capex / Revenue | -- | -- | -- | 1.8% | 1.3% | 1.4% | 1.8% | |
| SG&A / Revenue | 16.1% | -- | -- | 16.2% | 16.7% | 16.9% | 16.0% | |
Revenue CAGR
+4.3%
Net Income CAGR
-11.8%
EPS CAGR
-14.0%
FCF CAGR
+78.5%
Revenue YoY
+2.2%